|
|
Registries have shown it can take 7+ years to diagnose—would you recognize systemic mastocytosis?9
|
|
|
|
|
|
|
|
Skin lesions. Anaphylaxis. Diarrhea.1,3
|
|
Either alone or in combination, these are the hallmark symptoms of systemic mastocytosis (SM) that commonly appear with unexplained persistence or recurrence.1,3,4,9,10
|
|
Patients often present with 2 or more seemingly unrelated symptoms that may be driven by the KIT D816V mutation. The KIT D816V mutation is the central driver of systemic mastocytosis in ~95% of cases.1,3,9-11
|
|
There are also 20+ possible symptoms that could signal mast cell involvement. In some cases, systemic mastocytosis can lead to organ damage and shortened overall survival.5-8,12
|
|
Could KIT D816V be hiding in your practice? Learn more about uncovering this mutation, and find labs that test for KIT D816V using high-sensitivity assays.
|
|
|
|
References: 1. Gilreath JA, et al. Clin Pharmacol. 2019;11:77-92. 2. Theoharides TC, et al. N Engl J Med. 2015;373(2):163-172. 3. Hartmann K, et al. J Allergy Clin Immunol. 2016;137(1):35-45. 4. Shomali W, Gotlib J. Hematology Am Soc Hematol Educ Program. 2018(1):127-136. 5. Lim KH, et al. Blood. 2009;113(23):5727-5736. 6. Kibsgaard L, et al. Derm. 2020;6:294-300. 7. Sperr WR, et al. Lancet Haematol. 2019;6(12):e638-e649. 8. Trizuljak J, et al. Allergy. 2020;75(8):1927-1938. 9. Jennings SV, et al. Immunol Allergy Clin North Am. 2018;38(3):505-525. 10. Garcia-Montero AC, et al. Blood. 2006;108(7):2366-2372. 11. Verstovsek S. Eur J Haematol. 2013;90(2):89-98. 12. van Anrooij B, et al. Allergy. 2016;71(11):1585-1593.
|
|
This e-mail is intended for U.S. healthcare professionals only.
|
|
|
|
|
You can unsubscribe from Blueprint Medicines Corporation email marketing communications by clicking here
Blueprint Medicines
45 Sidney Street, Cambridge, MA 02139
Blueprint Medicines and associated logo are trademarks of Blueprint Medicines Corporation.
© 2022 Blueprint Medicines Corporation.
01/2022 USBP-PRSM-20.028.1
|
|
|